Selventa
One Alewife Center
Cambridge
Massachusetts
02140
United States
Tel: 617-547-5421
Fax: 617-547-5442
Website: http://www.selventa.com/
15 articles about Selventa
-
Selventa Strengthens Intellectual Property for System Diagnostics (SysDx) Approach to Personalized Medicine
5/8/2013
-
Seegene, Inc. and Selventa Form Strategic Collaboration to Develop Novel Molecular Diagnostics (MoDx)
4/23/2013
-
Selventa Developing Powerful New Class of Multi-omic Based Diagnostic Test for Autoimmune Disease and Cancer
1/22/2013
-
Selventa to Participate in a High Profile Panel on Companion Diagnostics at BIO-Europe 2012
11/5/2012
-
Selventa CEO David de Graaf Named as one of PharmaVOICE Magazine's "100 Most Inspiring People in the Life Sciences"
8/9/2012
-
Selventa Releases OpenBEL as Open Source and Encourages the Community to Participate in an OpenBEL Consortium
6/18/2012
-
Selventa Names William Hayes as Senior Vice President of Platform Development
4/17/2012
-
Selventa Announces a Research Agreement to Understand Mechanisms of Disease
2/27/2012
-
Selventa Granted Patent for Discovery of Biomarker Profiles
1/23/2012
-
Selventa and Linguamatics Ltd Announce Strategic Partnership to Provide a Complete Pipeline of Scientific Knowledge Extraction to their Life Science Partners
10/31/2011
-
Selventa's David de Graaf Appointed as a Scientific Advisory Board Member for Massachusetts Institute of Technology (MIT)'s Center for Cancer Systems Biology
9/12/2011
-
Selventa's CEO Appointed to Swiss Institute of Bioinformatics - SWISS-PROT's SAB
8/16/2011
-
Selventa Enhances Scientific Capability with the Appointment of James J. Collins and Mathukumali Vidyasagar as Scientific Advisors
6/27/2011
-
Selventa Names David A. Fryburg, M.D. as Chief Medical Officer
4/4/2011
-
Selventa Teams with Pfizer Inc. to Spread Drug Safety Knowledge
3/29/2011